Correlation Between Ningxia Younglight and Kontour Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningxia Younglight and Kontour Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningxia Younglight and Kontour Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningxia Younglight Chemicals and Kontour Medical Technology, you can compare the effects of market volatilities on Ningxia Younglight and Kontour Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningxia Younglight with a short position of Kontour Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningxia Younglight and Kontour Medical.

Diversification Opportunities for Ningxia Younglight and Kontour Medical

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ningxia and Kontour is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ningxia Younglight Chemicals and Kontour Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kontour Medical Tech and Ningxia Younglight is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningxia Younglight Chemicals are associated (or correlated) with Kontour Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kontour Medical Tech has no effect on the direction of Ningxia Younglight i.e., Ningxia Younglight and Kontour Medical go up and down completely randomly.

Pair Corralation between Ningxia Younglight and Kontour Medical

Assuming the 90 days trading horizon Ningxia Younglight Chemicals is expected to generate 1.01 times more return on investment than Kontour Medical. However, Ningxia Younglight is 1.01 times more volatile than Kontour Medical Technology. It trades about 0.0 of its potential returns per unit of risk. Kontour Medical Technology is currently generating about 0.0 per unit of risk. If you would invest  911.00  in Ningxia Younglight Chemicals on October 16, 2024 and sell it today you would lose (184.00) from holding Ningxia Younglight Chemicals or give up 20.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ningxia Younglight Chemicals  vs.  Kontour Medical Technology

 Performance 
       Timeline  
Ningxia Younglight 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ningxia Younglight Chemicals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningxia Younglight sustained solid returns over the last few months and may actually be approaching a breakup point.
Kontour Medical Tech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kontour Medical Technology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kontour Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Ningxia Younglight and Kontour Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningxia Younglight and Kontour Medical

The main advantage of trading using opposite Ningxia Younglight and Kontour Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningxia Younglight position performs unexpectedly, Kontour Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kontour Medical will offset losses from the drop in Kontour Medical's long position.
The idea behind Ningxia Younglight Chemicals and Kontour Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets